Emodin inhibits tumor metastasis in breast cancer by disrupting TGF-β1-mediated TAM-cancer cell interactions to halt EMT and stem cell formation [448], and modulating AKT/ERK signaling to attenuate metastatic potential in obesity/hyperlipidemia [471]. The gene discussed is TGFB1; the disease is breast cancer.